Cardinal Capital Management grew its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD – Free Report) by 6.2% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,645 shares of the medical instruments supplier’s stock after buying an additional 908 shares during the period. Cardinal Capital Management’s holdings in Utah Medical Products were worth $1,050,000 as of its most recent SEC filing.
Several other hedge funds also recently made changes to their positions in UTMD. Quadrature Capital Ltd grew its position in shares of Utah Medical Products by 177.6% during the 1st quarter. Quadrature Capital Ltd now owns 32,310 shares of the medical instruments supplier’s stock valued at $2,294,000 after buying an additional 20,671 shares during the last quarter. Penn Mutual Asset Management LLC grew its stake in Utah Medical Products by 46.3% during the 4th quarter. Penn Mutual Asset Management LLC now owns 53,093 shares of the medical instruments supplier’s stock worth $4,471,000 after buying an additional 16,810 shares during the last quarter. Isthmus Partners LLC increased its position in Utah Medical Products by 56.8% in the first quarter. Isthmus Partners LLC now owns 35,602 shares of the medical instruments supplier’s stock worth $2,532,000 after buying an additional 12,903 shares during the period. Vanguard Group Inc. lifted its stake in Utah Medical Products by 7.3% in the first quarter. Vanguard Group Inc. now owns 183,141 shares of the medical instruments supplier’s stock valued at $13,023,000 after buying an additional 12,402 shares during the last quarter. Finally, Los Angeles Capital Management LLC boosted its holdings in shares of Utah Medical Products by 127.0% during the first quarter. Los Angeles Capital Management LLC now owns 13,086 shares of the medical instruments supplier’s stock valued at $931,000 after acquiring an additional 7,320 shares during the period. Institutional investors and hedge funds own 69.60% of the company’s stock.
Utah Medical Products Price Performance
Shares of UTMD stock traded down $0.32 during trading hours on Friday, reaching $66.64. The stock had a trading volume of 8,474 shares, compared to its average volume of 23,188. The firm has a market capitalization of $235.24 million, a PE ratio of 14.81 and a beta of 0.06. The firm has a 50-day simple moving average of $68.10 and a 200-day simple moving average of $69.78. Utah Medical Products, Inc. has a twelve month low of $65.62 and a twelve month high of $96.82.
Utah Medical Products Dividend Announcement
Utah Medical Products Company Profile
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Read More
- Five stocks we like better than Utah Medical Products
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
- How to Buy Cheap Stocks Step by Step
- MarketBeat Week in Review – 8/5 – 8/9
- Consumer Discretionary Stocks Explained
- The Cannabis Sector: Profitability Takes Center Stage
Want to see what other hedge funds are holding UTMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Utah Medical Products, Inc. (NASDAQ:UTMD – Free Report).
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.